World-first: Daily tablet slows diabetes progression in clinical trial
A world-first clinical trial has found that baricitinib, a drug commonly prescribed for rheumatoid arthritis, preserved the pancreatic cells’ ability to produce their own insulin and slowed the progression of type 1 diabetes in those recently diagnosed… Continue reading World-first: Daily tablet slows diabetes progression in clinical trial